Fluoropharma Medical Stock Performance
| FPMI Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Fluoropharma Medical are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Fluoropharma Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Fluoropharma Medical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Total Cashflows From Investing Activities | -1293.00 |
Fluoropharma |
Fluoropharma Medical Relative Risk vs. Return Landscape
If you would invest 0.01 in Fluoropharma Medical on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Fluoropharma Medical or generate 0.0% return on investment over 90 days. Fluoropharma Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Fluoropharma, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Fluoropharma Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fluoropharma Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Fluoropharma Medical, and traders can use it to determine the average amount a Fluoropharma Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| FPMI |
Based on monthly moving average Fluoropharma Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fluoropharma Medical by adding Fluoropharma Medical to a well-diversified portfolio.
Fluoropharma Medical Fundamentals Growth
Fluoropharma Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Fluoropharma Medical, and Fluoropharma Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fluoropharma Pink Sheet performance.
| Return On Asset | -2.35 | |||
| Current Valuation | 9.23 M | |||
| Shares Outstanding | 34.26 M | |||
| Price To Earning | (0.39) X | |||
| Price To Book | 17.76 X | |||
| EBITDA | (2.16 M) | |||
| Cash And Equivalents | 24.72 K | |||
| Total Debt | 5.82 M | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | (0.30) X | |||
| Cash Flow From Operations | (880.12 K) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 334.76 K | |||
| Retained Earnings | (34.16 M) | |||
| Current Asset | 89 K | |||
| Current Liabilities | 10.32 M | |||
About Fluoropharma Medical Performance
By evaluating Fluoropharma Medical's fundamental ratios, stakeholders can gain valuable insights into Fluoropharma Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Fluoropharma Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fluoropharma Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Fluoropharma Medical performance evaluation
Checking the ongoing alerts about Fluoropharma Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Fluoropharma Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fluoropharma Medical generated a negative expected return over the last 90 days | |
| Fluoropharma Medical has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (2.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Fluoropharma Medical currently holds about 24.72 K in cash with (880.12 K) of positive cash flow from operations. |
- Analyzing Fluoropharma Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fluoropharma Medical's stock is overvalued or undervalued compared to its peers.
- Examining Fluoropharma Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fluoropharma Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fluoropharma Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fluoropharma Medical's pink sheet. These opinions can provide insight into Fluoropharma Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Fluoropharma Pink Sheet analysis
When running Fluoropharma Medical's price analysis, check to measure Fluoropharma Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluoropharma Medical is operating at the current time. Most of Fluoropharma Medical's value examination focuses on studying past and present price action to predict the probability of Fluoropharma Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluoropharma Medical's price. Additionally, you may evaluate how the addition of Fluoropharma Medical to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |